Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00432
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 8, 2020
Authors
Publisher
Frontiers Media SA